ProductProductWhat are Generics?
Vytorin
view photo
Generic Vytorin Simvastatin Ezetimibe 10mg + 10/20mg + 10mg

Generic Vytorin is used for treating high cholesterol along with a cholesterol-lowering diet. It works by reducing the amount of cholesterol that your body absorbs from your meals. Lowering cholesterol levels in the blood reduces the chance of heart disease, heart attacks and strokes.


Cholesterol


PackagePricePer pillSavingsOrder
10mg + 10mg × 30 pills$78.20$ 2.61 
10mg + 10mg × 60 pills$146.40$ 2.44  $10.00
10mg + 10mg × 90 pills$198.60$ 2.21  $36.00
10mg + 10mg × 120 pills$250.80$ 2.09  $62.00
PackagePricePer pillSavingsOrder
20mg + 10mg × 30 pills$110.40$ 3.68 
20mg + 10mg × 60 pills$214.80$ 3.58  $6.00
20mg + 10mg × 90 pills$301.20$ 3.35  $30.00
PRODUCT DESCRIPTION Show Product Info
Search for pillsSearch for pills

TestimonialsTestimonials
thank you, i recieved my pills within one week of ordering them, cheers for the extra 4 you threw in as a bonus, and yes they worked great, cheers again.....
Read more »Read more »
NewsNews
    US Judge Upholds Validity Of Merck's Vytorin Patent - Wall Street Journal
    US Judge Upholds Validity Of Merck's Vytorin PatentWall Street Journals (MRK) cholesterol-lowering drugs Vytorin and Zetia, which could stave off competing generic copies for several years
    Merck wins patent fight on Zetia, Vytorin; Fitch warns of 'pure pharma' risks; - FiercePharma
    Merck wins patent fight on Zetia, Vytorin; Fitch warns of 'pure pharma' risks;FiercePharmaArticle | Follow @FiercePharma > A US court upheld Merck's ($MRK) patent on the active ingredient ezetimibe, marketed as the cholesterol-lowering Zetia and in the combo cholesterol pill Vytorin
    Merck profit rises 67% on lower costs - MarketWatch
    BloombergMerck profit rises 67% on lower costsMarketWatch
    Stocks to watch Monday: Haemonetics, Merck - MarketWatch
    Stocks to watch Monday: Haemonetics, MerckMarketWatchCulminating more than two years of litigation, Merck (NYSE:MRK) said late Friday a federal court ruled in a patent case involving Zetia and Vytorin, saying that a patent held on an active ingredient in both drugs was enforceable and would remain in
    Investor Medical Waves - (VVUS, MRK, MYL, AMPE) - Galaxy Stocks
    Investor Medical Waves - (VVUS, MRK, MYL, AMPE)Galaxy StocksAccording to the company, sales of ZETIA were $614M in the 1Q 2012, while Vytorin's sales were $444M during the period
Live support Online Chat


Our billing is certified by
Secure shopping certificates